+ regulatory T cells (T regs ) are the key players that maintain immune tolerance. The mechanisms by which T regs regulate and suppress diverse immune cell subsets have been studied extensively, but the impact of T regs on basophil functions is not well understood. We report that human basophils are refractory to T reg -mediated suppression and found that T regs stimulate resting basophils to induce the expression of activation markers including CD69, CD203c, and CD13 and the release of basophil cytokines including IL-13, IL-8, and IL-4. Mechanistically, T regs could induce human basophil activation via IL-3 and STAT5 activation, whereas cellular contact was dispensable. Inhibition of either IL-3-IL-3 receptor interactions or STAT5 phosphorylation abrogated T reg -mediated activation of basophils. These results provide evidence of direct positive effects that human T regs have on basophil activation and reveal a previously unrecognized feature of this cell subset well known for immunosuppressive functions.
INTRODUCTION
Basophils are rare granulocytes (about 0.5% of total leukocytes) that are important for the protection against helminth parasites. In addition, basophils mediate T helper 2 (T H 2) responses, support B cell differentiation, and enhance humoral responses (1, 2) . Activated basophils produce several immunoregulatory cytokines such as interleukin-4 (IL-4), IL-13, IL-6, TSLP (thymic stromal lymphopoietin), and BAFF (B cell-activating factor) (1, 2) . Through these mediators, basophils regulate T and B cell responses and establish a critical link between innate and adaptive immunity (3, 4) .
Although rare in number, basophils are implicated in various pathological conditions, in part, due to their ability to undergo rapid activation in response to a wide range of stimuli and release of diverse immune mediators. Basophils are well known for their pathogenic role in allergic conditions through secretion of mediators of hypersensitivity reactions including histamine and leukotriene (1, 2, 5) . Many inflammatory skin diseases are characterized by basophil infiltration and activation (6) . Basophils are also reported to play a role in the pathogenesis of autoimmune and other inflammatory diseases (7) (8) (9) (10) (11) . Therefore, considering the impact of dysregulated functions of basophils on the immune response in various diseases, it is essential to understand the regulatory mechanisms by which basophils are kept in check.
In this regard, regulatory T cells (T regs ) have been widely studied for their role in immune tolerance and in the maintenance of immune homeostasis (12) (13) (14) . T regs modulate autoimmune and inflammatory responses by exerting direct suppressive effects on various immune cells including dendritic cells (DCs), T cells, macrophages, monocytes, B cells, natural killer cells, and mast cells (15) (16) (17) (18) (19) . These functions are mediated by inhibitory surface molecules [cytotoxic T lymphocyte antigen-4 (CTLA-4) and lymphocyte-activation gene-3 (LAG-3)], inhibitory cytokines [transforming growth factor- (TGF-), IL-10, and IL -35] , and cytotoxic molecules (granzyme and perforin). Although regulatory mechanisms by which T regs suppress different immune cell subsets have been extensively studied, the impact of T regs on basophil functions is not well understood. In view of emerging reports on the role of basophils in various pathological conditions, we investigated the interaction of T regs with human basophils and its effects on basophil functions.
Here, we report that in contrast to other immune cells, human basophils are refractory to T reg -mediated suppression. T regs did not inhibit anti-immunoglobulin E (IgE)-mediated activation of basophils. We found that T regs induce activation of resting basophils characterized by significantly enhanced expression of activation markers and secretion of several basophil cytokines such as IL-13, IL-8, and IL-4. Mechanistically, these stimulatory functions of T regs were mediated via IL-3 released from the activated T regs that triggered the signal transducer and activator of transcription 5 (STAT5) pathway in basophils, whereas cell-to-cell contact was dispensable. Inhibition of either IL-3-IL-3 receptor (CD123) interaction or STAT5 phospho rylation abrogated T reg -induced activation of basophils. These results demonstrate the direct positive effects of human T regs on basophil activation and uncover previously unrecognized features of these immunosuppressor cells.
RESULTS
Human basophils are refractory to T reg -mediated suppression Because T regs are classically known for their immunosuppressive functions, we first evaluated the ability of human T regs to suppress high-affinity receptor for Fc region of IgE (FcRI)-mediated basophil activation. In our assays, we used activated memory T regs that have F) , CD63 (G), and CD107a (H) on the basophils under various experimental conditions. (I) Amount of histamine released under above experimental conditions (mean ± SEM; n = 6). **P < 0.01, ***P < 0.001, and ****P < 0.0001; ns, not significant by one-way ANOVA with Tukey's multiple comparison test. 
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the ability to directly suppress target cells without the need for undergoing differentiation process (20) . Stimulation of basophils with anti-IgE antibodies that cross-link FcRI-bound IgE on the basophils led to a significant increase in the expression of various activation markers, including CD203c, CD13, and CD69, and degranulationassociated markers CD63 and CD107a (Fig. 1, A to H). T regs did not inhibit anti-IgE-mediated activation of basophils, and the expression of various activation-associated markers on "T reg -educated" basophils was on par with that of anti-IgE-stimulated control basophils and "conventional T cells (T conv )-educated" basophils ( Fig. 1, A to H ). The effect of T regs on the phenotype of basophils is reproduced in functional assays. We found that T regs did not inhibit histamine release from anti-IgE-activated basophils (Fig. 1I) . These results indicate that human basophils are refractory to T reg -mediated suppression.
Human basophils lack receptors to receive contact-dependent inhibitory signals from T regs We examined possible factors contributing to resistance of human basophils to T reg -mediated suppression. Suppression of target immune cells by T regs is attributed to both contact-dependent and contactindependent mechanisms (15, (21) (22) (23) (24) . CTLA-4 and LAG-3 play a critical role in contact-dependent suppression of target cells by T regs through interaction with CD80/CD86 and human leukocyte antigen-D related (HLA-DR), respectively (18, 25, 26) . However, human basophils from the circulation ( Fig. 2A ) (27) (28) (29) (30) and from secondary lymphoid organs such as spleen ( Fig. 2B ) (31) lacked the expression of HLA-DR and B7 costimulatory molecules under steady state and under stimulation conditions, although lipopolysaccharidestimulated DCs, used as positive control, were all positive for these molecules ( fig. S1 ). These results imply that the inability of T regs to suppress activation of human basophils is in part due to the absence of necessary receptors on basophils required to receive inhibitory signals. In addition, no significant differences in the viability of human basophils were observed when they were cocultured with T regs (Fig. 2, C and D) .
Human basophils are unresponsive to contact-independent inhibition by T regs
Several studies have demonstrated that T regs mediate immunosuppressive functions by cytokines, in particular, TGF- and IL-10 (21, 32, 33) . The lack of suppressive effects of T regs on human basophils raised an intriguing question on the expression of receptors for these cytokines. We found that circulating human basophils lack TGF-RII (Fig. 2E ), but IL-10R was expressed on a subset of circulating human basophils (40.3 ± 6.6%, n = 6 donors) (Fig. 2E) . Similar patterns of expression were observed on human splenic basophils ( fig. S2) .
We explored whether the IL-10R + subset of human basophils could be modulated by IL-10. Basophils were treated with increasing concentrations of IL-10 (from 100 pg to 10 ng/ml) for 24 hours and then stimulated with anti-IgE during the last hour of culture. Even at the highest concentration (10 ng/ml), IL-10 did not modify the expression of activation markers on IL-10R + or IL-10R − basophil subsets (Fig. 2F) . IL-10 suppressed the expression of various activation markers on DCs, thus confirming the biological activity of this cytokine ( fig. S3 ). Another report also indicated that IL-10 does not affect either IL-3 or IgE-mediated activation of human basophils (34) . These results provide a potential explanation for the refractoriness of human basophils to T reg -mediated suppression.
T regs induce the activation of resting basophils
Because T regs did not inhibit activation of human basophils, we examined the impact of activated T regs cocultured with resting basophils in the absence of any exogenous stimulation or cytokines for 24 hours. T regs induced the activation of human basophils, as indicated by strongly increased expression of the activation markers CD13, CD203c, and CD69 (Fig. 3, A and B) . However, expression of CD63 and CD107a, the markers associated with basophil degranulation, remained unaltered (Fig. 3 , C and D), indicating that T reg -induced activation of human basophils is not associated with degranulation. We confirmed that enhanced expression of activation markers on basophils upon coculture with T regs was not due to nonspecific stimulation of basophils by anti-CD3 and anti-CD28 monoclonal antibodies (mAbs) used for the activation of T regs because the phenotype of basophils was not altered when they were cultured with these mAbs ( fig. S4 ).
T reg -induced activation of human basophils was not restricted to phenotypic changes, and functional analysis of basophils also confirmed their activation. T regs significantly induced the secretion of IL-13 and IL-8 from basophils (Fig. 4, A and B) . Although significant, induction of IL-4 was minimal (Fig. 4C) . Analysis of cytokines produced by activated T regs alone at equivalent numbers revealed that they produced minimal amounts of IL-13 [13.1 ± 4.4 pg/ml (mean ± SEM); n = 8], IL-8 (13.5 ± 5.1 pg/ml; n = 8), and IL-4 (7.3 ± 3.0 pg/ml; n = 8 donors). Together, these results demonstrate that T regs induce the activation of human basophils, as evidenced by phenotypic changes and secretion of cytokines (Figs. 3 and 4).
Cell adhesion is dispensable for T reg -induced activation of human basophils
We aimed to identify the mechanism(s) by which T regs induce activation of human basophils. Interaction of LFA-1 (CD11a/CD18) on T regs with intercellular adhesion molecule-1 (ICAM-1) (CD54) mediates adhesion and aggregation of T regs on DCs (35) (36) (37) . Previous studies have reported the expression of ICAM-1 on basophil cell lines and circulating human basophils (38, 39) . We confirmed the expression of ICAM-1 on resting human basophils, which was enhanced upon IL-3 stimulation (Fig. 5A ). ICAM-1 blockade did not abrogate T reg -induced activation of basophils ( (A to C) Supernatants of cocultures were analyzed for the amounts of (pg/ml; mean ± SEM; n = 6 independent experiments using cells from different donors) IL-13 (A), IL-8 (B), and IL-4 (C). *P < 0.05 by two-tailed paired Student's t test.
that adhesion of T regs to basophils is dispensable for T reg -induced activation of basophils.
We performed Transwell experiments to confirm that cell-to-cell contact is dispensable for stimulating basophil activation by T regs . Preactivated T regs were placed in the upper chamber and basophils in the lower chamber of the Transwell system. T regs in transwells induced significant expression of basophil activation markers (CD13, CD203c, and CD69). The expression levels of activation markers were equivalent to levels induced on basophils cocultured with T regs without Transwell conditions (Fig. 5E ). The leakproof nature of Transwell was confirmed by the absence of CD4 + T cells in the lower chambers of Transwell ( fig. S7 ).
Soluble mediators released from activated T regs stimulate basophils
Because cell contact was found not to be required for T reg -induced human basophil activation, we explored whether soluble mediators released by activated T regs mediate basophil stimulation. To examine this, we cultured resting basophils with cell-free supernatants from either unstimulated or anti-CD3/anti-CD28-stimulated T regs . Supernatants from unstimulated T regs did not modify the expression of activation markers on basophils (Fig. 6) . However, basophils cultured with the supernatants from stimulated T regs showed significantly enhanced expression of CD13, CD203c, and CD69 (Fig. 6A) but not degranulation-associated , and CD69 (mean ± SEM; n = 4 independent experiments using cells from different donors) on the basophils. (E) Expression of CD13, CD203c, and CD69 (mean ± SEM; n = 5 independent experiments using cells from different donors) on the basophils cocultured with T regs either in direct contact or in transwells. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; ns, not significant by one-way ANOVA with Tukey's multiple comparison test. markers CD63 and CD107a (Fig. 6B) . The expression pattern of these activation markers was identical to basophils cocultured with activated T regs (Fig. 3) . These results thus confirm a role for soluble mediator(s) released from activated T regs in stimulating basophil activation.
T regs induce human basophil activation by an IL-3-dependent mechanism
Previous reports have shown that IL-3 plays a crucial role not only in the survival (40, 41) but also in the activation of basophils (39, 42, 43) .
IL-3 directly induces and enhances several activation-linked markers on human basophils, such as CD69, CD203c, and CD13 (39, 44) , and stimulates secretion of cytokines including IL-13 (45) . The expression of activation markers and secretion of cytokines by human basophils cocultured with T regs were reminiscent of IL-3 activity on basophils.
Several recent articles identified activated CD4
+ T cells as a major source of IL-3 (46) (47) (48) . We found that anti-CD3/ anti-CD28-activated T regs secrete IL-3 in the range of 148 ± 25 pg per million cells (mean ± SEM; n = 11 donors), whereas resting T regs did not secrete detectable levels of IL-3 ( fig. S8) . A dose-response study indicated that treatment of human basophils with IL-3 at a concentration equivalent to that secreted by human T regs could induce activation ( fig. S9 ). These data thus validate that the quantity of IL-3 produced by T regs is sufficient to induce basophil activation.
To demonstrate unequivocally that T regs induce human basophil activation by an IL-3-dependent mechanism, we followed two independent approaches: blockade of IL-3 interaction with its receptor (IL-3R) and inhibition of IL-3-mediated signal transduction pathway. First, we blocked IL-3R on basophils before coculture with activated T regs . Consistent with our hypothesis, the expression of T reg -induced activation markers CD203c, CD13, CD69, and FcRI on basophils was significantly reduced upon IL-3R blockade (Fig. 7, A and B) . In addition, IL-3R blockade also decreased T reg -induced secretion of IL-8 and IL-13 by basophils (Fig. 7C) .
IL-3 promotes priming of basophils for FcRI-mediated degranulation and for the release of inflammatory mediators. In response to degranulation signals, T regactivated basophils showed significantly enhanced expression of degranulationassociated molecules CD107a and CD63 and released histamine at levels similar to that observed with IL-3-FcRI-activated basophils ( fig. S10 ). These data confirm that T reg -activated basophils are functionally fit and that T regs license basophils to undergo activation by degranulation signals.
To further authenticate that IL-3 signaling is implicated in the T regmediated activation of basophils, we investigated STAT5 pathway (34) . T regs induced phosphorylation of STAT5 in basophils at levels similar to that observed by treatment with IL-3 used at an equivalent concentration produced by stimulated T regs (Fig. 8, A and B) . STAT5 inhibition in basophils led to abrogation of T reg -induced activation markers CD13, CD203c, and CD69 on basophils (Fig. 8C) and the , and CD69 (A) and degranulation markers CD63 and CD107a on the basophils (B) (mean ± SEM; n = 3 independent experiments using cells from different donors). *P < 0.05 and **P < 0.01; ns, not significant by one-way ANOVA with Tukey's multiple comparison test.
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secretion of IL-13 and IL-8 (Fig. 8D) . These data together demonstrate that IL-3 plays a critical role in inducing T reg -mediated activation of human basophils.
DISCUSSION
Here, we found that human basophils not only show unique refractoriness toward T reg -mediated-suppressive effects but also undergo activation by T regs . In mice, basophils and antigen-specific T cells were reported to be engaged in multiple serial interactions of short to moderate duration in the tissues (47) . However, mouse and human basophils display differences in the expression of costimulatory and antigenpresenting molecules that play a critical role in the cross-talk between innate and T cells (27) (28) (29) (30) (49) (50) (51) (52) (53) . Therefore, cognate interaction as in the case of classical antigen-presenting cells (APCs) and T regs (54) is unlikely in the case of human basophils. Both T regs and basophils are present in secondary lymphoid organs and in the peripheral tissues (31, 55, 56) . In these sites, T regs constantly receive activation signals from APCs, leading to the secretion of IL-3. Consequently, without involving cognate interaction, IL-3 secreted from activated T regs could affect basophils both at secondary lymphoid organs and at peripheral tissues.
Basophils play an important role in the protection against helminth parasites, and various lines of evidence provide a pointer that IL-3 is central for these functions by supporting survival of basophils and and IL-8 (mean ± SEM; n = 5 independent experiments using cells from different donors) by basophils. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by one-way ANOVA with Tukey's multiple comparison test.
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promoting basophilia (57-59). IL-3 synergizes with basophil-derived IL-4 and IL-13 to promote the alternative activation of monocytes (60) . Alternative or M2-type monocyte-macrophages are well recognized for their anti-inflammatory functions and for protection against nematode parasite (61) . Thus, we propose that in vivo, under physiological conditions, T regs might contribute to controlling the inflammation and to fighting helminth infection by promoting basophilia, by enhancing the survival and activation of basophils via an IL-3-dependent mechanism, and by inducing IL-4 and IL-13. Although activation of human basophils by T regs led to induction of these cytokines, the effect on IL-13 secretion was particularly prominent. On the basis of the current evidence, it appears that IL-4 response by human basophils is mostly dependent on IgE/FcRI cross-linking. However, IL-13 could be induced in basophils by IgE/FcRI-independent signaling as well (62) . In this regard, IL-3 has been reported to provide adequate stimulus to induce IL-13 secretion by human basophils (44, 63) . Because T regs induced the , and CD69 on the basophils (C) and the amounts of IL-13 and IL-8 in the culture supernatants (D) (mean ± SEM; n = 4 independent experiments). *P < 0.05, **P < 0.01, and ****P < 0.0001; ns, not significant by one-way ANOVA with Tukey's multiple comparison test. activation of human basophils via an IL-3-dependent mechanism, it provides an explanation for low induction of IL-4 and higher secretion of IL-13 by basophils. Abrogation of IL-13 (and IL-8) production by basophils either upon IL-3R blockade or upon STAT5 inhibition further validates that these cytokines are contributed mainly by basophils.
Our study is limited to polyclonal CD4 (20) . Moreover, on the basis of the expression of chemokine receptors CXCR3, CCR4, CCR10, and CCR6, memory T regs were further classified into various effector T H -like T reg subsets (T H 1-T reg , T H 2-T reg , T H 17-T reg , and T H 1/T H 17-T reg ) that are immunosuppressive and FoxP3 + but secrete effector cytokine(s) of a corresponding T H subset (64) (65) (66) (67) (68) . Therefore, it is likely that IL-3 secretion pattern might vary among these distinct T reg subsets and, as a consequence, their effect on basophil activation. In addition, IL-3 production by T regs might also be influenced by signals they receive in the microenvironment and, in particular, signals by basophils. Detailed analyses of the influence of basophils on T reg plasticity, phenotype, functions, and cytokine secretion pattern, particularly IL-3, should shed light on these points. Although chronic inflammation promotes pathogenic reprogramming of T regs into T H cells (69, 70) , this might not be the case in our study because basophil-T regs were cultured only for 24 hours. Another area that requires further exploration is whether IL-3 production and suppressive functions of T regs are connected or are an independent process. It was suggested that reduced number and/or function of FoxP3 + T regs in several immunodeficiencies such as immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX), Omenn syndrome, and Wiskott-Aldrich syndrome leads to enhanced T H 2 cytokine production and, as a consequence, increased IgE levels (71) . Defective functions of T regs are also reported in diverse autoimmune and inflammatory diseases (72) . A comparative analysis of T reg functions and IL-3 production in healthy versus immunodeficient and autoimmune patients and their repercussion on basophil functions needs to be performed.
Multiple subsets of T regs play an important role in the suppression of allergic responses both during sensitization phase and during effector phase by targeting various cell types (73) . However, few reports indicated that the frequency of CD4 + CD25 + T regs is increased in patients with allergic rhinitis, atopic dermatitis, and atopic and bronchial asthma (74) (75) (76) . In addition, the number of T regs has increased during exacerbation of asthma and allergic rhinitis (75, 76) . Although increased T regs observed in these patients might represent response of the host to curtail pathogenic responses, on the contrary, our current data suggest that enhanced T reg response observed in these patients might even aggravate allergic responses by activating basophils in an IL-3-dependent manner to induce IL-13 and IL-4 that are T H 2-associated cytokines and support IgE class switch. The T reg number in pediatric patients with allergic rhinitis and bronchial asthma was reported to correlate positively with total IgE level (75) . It is therefore likely that various specialized subsets of regulatory cells participate in the control of different arms of allergic response and that a particular T reg subset alone might not efficiently control allergic responses (77) (78) (79) (80) . For example, in allergic rhinitis patients, deficiency of allergen-specific IL-10-producing Tr1 subset found to be associated with disease severity, although the number and function of CD4 + CD25 + T regs in these patients did not change (81). Therefore, detailed investigation of various T reg subsets is crucial for establishing their correlation with diseases severity in allergic diseases. Considering that CD4 + CD25 + FoxP3 + T regs activate basophils and could license them to undergo degranulation, leading to histamine release, we suggest that simultaneous blocking of basophil responses is necessary to attain maximum benefits of T reg -targeted therapeutic approaches for allergic conditions.
MATERIALS AND METHODS
Study design
This research was designed to investigate the regulation of human basophil functions by CD4
+ T regs and to identify underlying mechanisms. Cells were isolated from the buffy bags of healthy adult blood donors. Because there was no intervention, blinding and randomization were not used. Depending on the number of experimental groups, our experimental design used repeated-measures analysis of variance (ANOVA) or Student's t test to measure the level of significance. Acquisition of data from multiple independent donors for each of the parameters permitted us to control interindividual variations in the experiments.
Isolation of basophils
Buffy bags of healthy donors were subjected to Ficoll density gradient centrifugation and cellular fractions containing peripheral blood mononuclear cells (PBMCs), and basophils were collected. Basophils were isolated from these cells by using Basophil Isolation kit II (Miltenyi Biotec) and autoMACS. The purity of basophils was 96 ± 0.5%, as analyzed by flow cytometry. (fig. S11 ). The purity of various T cell populations was 96 ± 3%.
Regulatory T cells
CFSE labeling of CD4
+ T cells CD4 + T cells were washed and resuspended in phosphate-buffered saline (10 × 10 6 cells/ml). Cells were incubated with carboxyfluorescein succinimidyl ester (CFSE; 5 M; BD Biosciences) at 37°C in a water bath for 10 min, followed by thorough washing with the medium. Labeled CD4 + T cells were resuspended in X-VIVO medium at a concentration of 10 6 cells/ml.
T reg suppression assay
For analyzing the suppression of T conv proliferation by T regs ( fig. S11B ), CFSE-labeled T conv cells were cultured in serum-free X-VIVO 15 medium either alone (0.1 × 10 6 cells per 200 l) or with T regs at 1:3 ratio in the presence of plate-bound anti-CD3 mAb (1 g/ml) and soluble anti-CD28 mAb (1 g/ml). After 5 days, proliferation of T conv cells was analyzed by flow cytometry based on the dilution of CFSE.
Coculture of basophils with T regs or T conv
To investigate the effect of T regs on anti-IgE-mediated activation of human basophils, we cultured basophils (0. To analyze whether soluble mediators released from T regs induce basophil activation, we cultured T regs (0.3 × 10 6 cells) either alone (resting phase) in serum-free X-VIVO 15 medium or stimulated with anti-CD3 and anti-CD28 mAbs for 24 hours. Cell-free culture supernatants were harvested, and basophils (0.1 × 10 6 cells per well) were cultured for 24 hours either alone in serum-free X-VIVO 15 medium or in the presence of supernatants obtained from unstimulated or stimulated T regs .
For Transwell experiments, T regs (0.3 × 10 6 cells per 100 l) were preactivated with anti-CD3 and anti-CD28 mAbs for 24 hours. Basophils were placed in the lower chambers of transwells (Transwell→, 0.4 m; Corning), and preactivated T regs were added to the upper chambers of Transwell. The cells were cultured for 24 hours.
To analyze STAT5 activation, we cocultured basophils with preactivated T regs (0.3 × 10 6 cells per 200 l) at 1:3 ratio for 6 hours. As a positive control, basophils (0.1 × 10 6 cells per 200 l) were treated with IL-3 (100 pg/ml, an equivalent concentration produced by stimulated T regs ) for 6 hours. Cells were stained with anti-STAT5 (pY694) or isotype control mAbs by using Cell Signaling Buffer Set A (Miltenyi Biotec).
To confirm the role of STAT5 in T reg -induced basophil activation, we pretreated basophils (0.1 × 10 6 cells per 200 l) with STAT5 inhibitor CAS 285986-31-4 (20 M; Merck Millipore) or equivalent volume of dimethyl sulfoxide (DMSO) for 2 hours, followed by coculture with T regs (0.3 × 10 6 cells) for 24 hours. T regs in the coculture were stimulated with anti-CD3 and anti-CD28 mAbs.
To determine whether T reg -activated basophils are functionally fit and T regs license basophils to undergo activation by degranulation signals, we cocultured basophils (0.1 × 10 6 cells per 200 l) with T regs (0.3 × 10 6 cells per 200 l) for 24 hours in the presence of anti-CD3 and anti-CD28 mAbs. During the last 1-hour culture, anti-IgE antibodies (2 ng per 0.1 × 10 6 basophils) were added to stimulate the basophils.
Basophil response was examined by analyzing the expression of activation-associated markers by flow cytometry. Cell-free culture supernatants were collected from basophil-T reg coculture experiments and subjected for the analysis of histamine or cytokines. 
Treatment of basophils with IL-10
Culture of DCs
Monocytes from PBMCs were isolated by using CD14 microbeads (Miltenyi Biotec). Monocytes were differentiated to DCs by culturing them with rhIL-4 (500 IU per 10 6 cells) and rhGM-CSF (recombinant human granulocyte-macrophage colony-stimulating factor; 1000 IU per 10 6 cells) (both from Miltenyi Biotec) for 6 days. Differentiation of DCs was confirmed by the analysis of surface markers. In addition, DCs were also stimulated with lipopolysaccharide from Escherichia coli O55:B5 (10 ng per 0.5 × 10 6 cells; Sigma-Aldrich) for 24 hours and analyzed for the expression of maturation-associated markers.
To analyze the effect of IL-10 on DCs, we treated cells with rhIL-10 (10 ng/ml per 0.5 × 10 6 cells) for 24 hours, followed by analysis of surface markers by flow cytometry. To explore the effect of ICAM-1 blockade toward DC-mediated CD4 + T cell proliferation, we preincubated DCs with ICAM-1 blocking mAb (20 g/ml) or isotype control mAb for 2 hours, followed by coculture with CFSE-labeled allogeneic CD4 + T cells (0.1 × 10 6 T cells per well) at 1:20 ratio in a total volume of 200 l for 5 days.
Measurement of histamine and cytokines
Histamine was measured in the culture supernatants by Histamine EIA kit (Bertin Pharma). IL-3 (Quantikine ELISA kit, R&D Systems), IL-8, IL-13, and IL-4 (ELISA Ready-SET-Go, eBioscience) were analyzed in the culture supernatants by enzyme-linked immunosorbent assay (ELISA).
Statistical analysis
Statistical analyses were performed by GraphPad Prism 6 software. Data were analyzed by one-way ANOVA with Tukey's multiple comparison tests ( = 0.05) or two-tailed paired Student's t test, as indicated. Two-way ANOVA with least significant difference was used to analyze Fig. 2F . Data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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